Galectin Therapeutics (NasdaqCM:GALT) Update / briefing March 10, 2026 12:00 PM ET Company ParticipantsKhurram Jamil - CMOMichael Cozart - Managing PartnerNaga P. Chalasani - David W. Crabb Professor of Gastroenterology and HepatologyNaim Alkhouri - Chief Academic OfficerOperatorGood afternoon, and welcome to the Galectin Therapeutics Virtual KOL event. At this time, all attendees are in a listen-only mode. A question and answer session will follow formal presentations. If you'd like to submit a question, y ...